Stay updated on ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Sign up to get notified when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.

Latest updates to the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page
- CheckyesterdayChange DetectedFooter revision label updated from v3.4.3 to v3.5.0. This reflects a new version of the site software.SummaryDifference0.1%

- Check8 days agoChange DetectedThe history shows a new site revision entry v3.4.3 added, with the previous v3.4.2 entry removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe latest version adds and updates entries in Study Status and Recruitment Status, including a new 'Has Not Concluded' designation and a subsequent status update.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry 'Revision: v3.4.2' was added to the history, and the funding/operating-status banner from v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check43 days agoChange DetectedAdded a site-wide notice about government funding lapse and operating status, and updated the revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check50 days agoChange DetectedThe new screenshot shows UI updates such as a glossary toggle display, green and red highlights to indicate additions and deletions, and updated footer labels including No FEAR Act Data with a revision tag (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.